Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F8D8K
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,820
Award facts
- Contract value 100% obligated
- $12,820.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,820.25 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injections on November 25, 2025. This firm fixed-price delivery order, which is expected to be completed by November 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, and the product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a GLP-1 receptor agonist medication used for weight management, reflecting the federal government's pharmaceutical procurement needs for military and veteran healthcare systems.
This delivery order is issued against AmerisourceBergen's comprehensive $999.99 billion IDC with DLA Troop Support Medical (SPE2DX) that extends through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor in the federal medical supply chain, providing an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The company's demonstrated capability to fulfill diverse pharmaceutical requirements through competitive procurement positions it as a key supplier for military healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F8D8K?
SPE2DR26F8D8K was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26F8D8K worth?
The government has obligated $12,820 on SPE2DR26F8D8K.
Is contract SPE2DR26F8D8K an order under another contract?
Yes. SPE2DR26F8D8K is a delivery order under SPE2DR25D3202, an indefinite delivery contract.
Was contract SPE2DR26F8D8K competed?
The extent of competition for SPE2DR26F8D8K was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award